Md Abu Musa

6PUBLICATIONS
22CO-AUTHORS
Molecular targetsPredictive and prognostic markersAutoimmunityMolecular medicineGenetically modified horticulture plants
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 15, 2026
The role of RAD23A in DNA repair and proteasome-dependent protein degradation in multiple myeloma.

|Feb 03, 2026
Proteasome subunit PSMD1 is a key therapeutic target in multiple myeloma.

Ting Du, Teng Fang, Sindhu C Pillai

|May 01, 2025
Targeting Siglec-sialic acid checkpoint to reverse immune dysfunction mediated by plasmacytoid dendritic cells in myeloma.

Arghya Ray, Leutz Buon, Xueping Wan

|Apr 09, 2024
A novel small molecule inhibitor of CD73 triggers immune-mediated multiple myeloma cell death.

Arghya Ray, Ting Du, Xueping Wan

|Jul 12, 2020
A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editing.

Wen-Wei Zhang, Subir Karmakar, Sreenivas Gannavaram

|Nov 19, 2019
Lymphocytes influence Leishmania major pathogenesis in a strain-dependent manner.

Md Abu Musa, Risa Nakamura, Asma Hena

Pageof 1

Frequent Collaborators

3 joint publications

Minxing Wang

2 joint publications

Filip Garbicz

2 joint publications

Sindhu C Pillai

2 joint publications

Kenneth C Anderson